Duke Cancer Network — Durham, North Carolina

Duke Cancer Network is a clinical research site located in Durham, North Carolina, United States 27713.

Crixeo Health Trust Score: 70/100 (FAIR). This profile has not yet been claimed by the site owner.

Duke Cancer Network has participated in 4 clinical trials with 3 currently active.

Therapeutic areas: Advanced Breast Cancer, Advanced Prostate Cancer, Advanced Lung Cancer.

Sponsors: Duke University, Novartis Pharmaceuticals, Prostate Cancer Clinical Trials Consortium.

Sponsor Feasibility Report

Trust Score: 70/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Duke Cancer Network?

Duke Cancer Network has a Crixeo Trust Score of 70/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Duke Cancer Network conducted?

Duke Cancer Network has 4 clinical trials on record, with 3 currently active. Their work covers Advanced Breast Cancer, Advanced Prostate Cancer, Advanced Lung Cancer.

Is Duke Cancer Network accredited by Crixeo Health?

Yes — Duke Cancer Network holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Duke Cancer Network?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.